MedPath

Comparison of the effect of two drugs Levetiracetam and Na-valproate in the treatment of generalized tonic clonic seizures

Phase 3
Recruiting
Conditions
Epilepsy.
Lennox-Gastaut syndrome
Registration Number
IRCT20190108042287N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Children aged 5-13 years old
Children suffering generalized tonic-clonic seizures

Exclusion Criteria

Electrolyte imbalance in creatinine and urea nitrogen blood
Sensitivity to drug

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence of seizure. Timepoint: Every 6 months for one year. Method of measurement: Using EEG.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath